ArticleWorld journal of orthopedics2026
Risk factors for thoracic-osteoporotic thoracic vertebral compression fractures during the normalized prevention and control period of COVID-19.
Article in World journal of orthopedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endocrine complications of COVID-19: diabetes, musculoskeletal, thyroid, pituitary, adrenal, and gonadal disorders.Journal of the Endocrine Society · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSome scholars believe that there is a certain correlation between coronavirus disease 2019 (COVID-19) infection and the occurrence of osteoporotic vertebral compression fractures (OVCF), but no relevant domestic research reports have been published yet. This study retrospectively analyzed the clinical data of patients admitted for OVCF and treated with percutaneous vertebroplasty during the normalized prevention and control period of COVID-19 in Shanghai (after June 1, 2022), aiming to explore the individual differences of OVCF patients during this special period and analyze the risk factors for OVCF.
aimTo explore risk factors for senile OVCF during COVID-19 normalization.
methodsRetrospective analysis of 230 OVCF patients (June 2022 to June 2023, percutaneous vertebroplasty, observation group) and 236 controls (June 2020 to June 2021, OVCF surgery). Observation group was split into nucleic acid-positive (
resultsObservation group had 42.2% thoracic fractures and 38.2% cough-induced fractures (both higher than controls,
conclusionDuring COVID-19 normalization, cough is the top OVCF cause; thoracic fractures rise. The four factors above are independent risks. For elderly COVID-positive patients with recurrent cough, lung disease treatment, anti-osteoporosis therapy, and thoracic braces prevent thoracic OVCF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.